Loading...
Clinical laboratory experience of blood CRIM testing in infantile Pompe disease
Cross-reactive immunological material (CRIM) status is an important prognostic factor in patients with infantile Pompe disease (IPD) being treated with enzyme replacement therapy. Western blot analysis of cultured skin fibroblast lysates has been the gold standard for determining CRIM status. Here,...
Na minha lista:
| Udgivet i: | Mol Genet Metab Rep |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674832/ https://ncbi.nlm.nih.gov/pubmed/26693141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgmr.2015.10.012 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|